Literature DB >> 33941816

8806 Russian patients demonstrate T cell count as better marker of COVID-19 clinical course severity than SARS-CoV-2 viral load.

Konstantin S Sharov1.   

Abstract

The article presents a comparative analysis of SARS-CoV-2 viral load (VL), T lymphocyte count and respiratory index PaO2:FiO2 ratio as prospective markers of COVID-19 course severity and prognosis. 8806 patients and asymptomatic carriers were investigated in time interval 15 March-19 December 2020. T cell count demonstrated better applicability as a marker of aggravating COVID-19 clinical course and unfavourable disease prognosis than SARS-CoV-2 VL or PaO2:FiO2 ratio taken alone. Using T cell count in clinical practice may provide an opportunity of early prediction of deteriorating a patient's state.

Entities:  

Year:  2021        PMID: 33941816     DOI: 10.1038/s41598-021-88714-6

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  39 in total

Review 1.  Transmission of SARS-CoV-2 by Children.

Authors:  Joanna Merckx; Jeremy A Labrecque; Jay S Kaufman
Journal:  Dtsch Arztebl Int       Date:  2020-08-17       Impact factor: 5.594

2.  Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients.

Authors:  Fengting Yu; Liting Yan; Nan Wang; Siyuan Yang; Linghang Wang; Yunxia Tang; Guiju Gao; Sa Wang; Chengjie Ma; Ruming Xie; Fang Wang; Chianru Tan; Lingxiang Zhu; Yong Guo; Fujie Zhang
Journal:  Clin Infect Dis       Date:  2020-07-28       Impact factor: 9.079

3.  SARS-CoV-2-IgG response is different in COVID-19 outpatients and asymptomatic contact persons.

Authors:  Nele Wellinghausen; Dietmar Plonné; Meike Voss; Ralitsa Ivanova; Reinhard Frodl; Susanne Deininger
Journal:  J Clin Virol       Date:  2020-07-06       Impact factor: 3.168

4.  A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: An observational cohort study.

Authors:  James B Galloway; Sam Norton; Richard D Barker; Andrew Brookes; Ivana Carey; Benjamin D Clarke; Raeesa Jina; Carole Reid; Mark D Russell; Ruth Sneep; Leah Sugarman; Sarah Williams; Mark Yates; James Teo; Ajay M Shah; Fleur Cantle
Journal:  J Infect       Date:  2020-05-29       Impact factor: 6.072

5.  Prediction Model Based on the Combination of Cytokines and Lymphocyte Subsets for Prognosis of SARS-CoV-2 Infection.

Authors:  Ying Luo; Liyan Mao; Xu Yuan; Ying Xue; Qun Lin; Guoxing Tang; Huijuan Song; Feng Wang; Ziyong Sun
Journal:  J Clin Immunol       Date:  2020-07-13       Impact factor: 8.317

Review 6.  Laboratory characteristics of patients infected with the novel SARS-CoV-2 virus.

Authors:  Chrysanthi Skevaki; Paraskevi C Fragkou; Chongsheng Cheng; Min Xie; Harald Renz
Journal:  J Infect       Date:  2020-06-21       Impact factor: 6.072

7.  Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards.

Authors:  Bernard La Scola; Marion Le Bideau; Julien Andreani; Van Thuan Hoang; Clio Grimaldier; Philippe Colson; Philippe Gautret; Didier Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-04-27       Impact factor: 3.267

8.  SARS-CoV-2-induced immunodysregulation and the need for higher clinical suspicion for co-infection and secondary infection in COVID-19 patients.

Authors:  Allison Parrill; Tiffany Tsao; Vinh Dong; Nguyen Tien Huy
Journal:  J Microbiol Immunol Infect       Date:  2020-09-08       Impact factor: 4.399

9.  SARS-CoV-2 Viral Load in Clinical Samples from Critically Ill Patients.

Authors:  Yongbo Huang; Sibei Chen; Zifeng Yang; Wenda Guan; Dongdong Liu; Zhimin Lin; Yu Zhang; Zhiheng Xu; Xiaoqing Liu; Yimin Li
Journal:  Am J Respir Crit Care Med       Date:  2020-06-01       Impact factor: 21.405

10.  Modeling the viral dynamics of SARS-CoV-2 infection.

Authors:  Sunpeng Wang; Yang Pan; Quanyi Wang; Hongyu Miao; Ashley N Brown; Libin Rong
Journal:  Math Biosci       Date:  2020-08-06       Impact factor: 2.144

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.